We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mobile Phone Text for Optimizing Asthma Treatment

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00917410
First Posted: June 10, 2009
Last Update Posted: June 10, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
MedicoMonitor Aps
The Ministry of Health and Prevention, Denmark
Information provided by:
University of Copenhagen
  Purpose

The study aims at providing information on how the Short Message Service (SMS) tool influences self-management in asthma patients and to assess the resulting health related effect. A wide range of models and theories exist in the compliance area, such as technical models, communication models, cognitive models and self-management models and theories. The use of some of these theories and models will serve as theoretical and explanatory tools for studying how and why the SMS tool influences the patient's self-management.

Objective:

The objective of this study is to assess the health-related effects of a SMS compliance and monitoring system for optimized asthma treatment in a controlled trial setting.


Condition Intervention
Asthma Behavioral: SMS support

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Assessment of the Health Related Effects of Compliance Optimization in Asthma Through Use of SMS (Short Message System) - A Controlled Trial

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • Asthma control test
  • EQ-5D [ Time Frame: 0, 45, 90 days ]
  • Use of health services [ Time Frame: 0, 45, 90 days ]
  • Use of preventive medicine [ Time Frame: 0, 45, 90 days ]

Enrollment: 244
Study Start Date: November 2007
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: SMS intervention Behavioral: SMS support

The intervention consisted of sequences of SMS messages sent to the intervention group, each containing 2 or 3 monitoring questions and one reminder to take the preventive medication. The SMS sequence was as follows.

  1. Remember to take your preventive asthma medication (sent at 8.00 am).
  2. Were you awakened during the night due to your asthma? Answer YES or NO.
  3. How many times have you taken your asthma attack medication during the last 24 hours? Answer a number.
  4. What was your peak flow this morning? Answer a number (optional, depending on the participant's use of a spirometer prior to the study).

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • asthmatics

Exclusion Criteria:

  • below 18 and above 45
  • COPD patients
  • no mobile phone
  • not using the prescribed asthma inhalation medication
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00917410


Locations
Denmark
University of Copenhagen
Copenhagen, Denmark, 2100
Sponsors and Collaborators
University of Copenhagen
MedicoMonitor Aps
The Ministry of Health and Prevention, Denmark
Investigators
Principal Investigator: Claus Møldrup, PhD University of Copenhagen
  More Information

Responsible Party: Claus Møldrup, Associate Professor PhD, University of Copenhagen
ClinicalTrials.gov Identifier: NCT00917410     History of Changes
Other Study ID Numbers: UC-SMS-01
First Submitted: June 5, 2009
First Posted: June 10, 2009
Last Update Posted: June 10, 2009
Last Verified: June 2009

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases